Rayno Tools and Molecular Diagnostics: Looking For Value
Looking for Value in a Slow Growth Market Life Science stocks took a big hit over the past summer and many have not fully recovered.The important metric to watch is sales growth because many of the smaller cap companies are still lagging in earnings growth so the PE tells you very little. The...
Sierra SnowBlog: First Snow of Season-Snowing Now…Update-2
11/9/15 A new storm from the North is bringing a fresh 6 in to Mammoth Mountain with more to come today. Looking out two weeks no major storms are on the horizon. 11/3 Update.. Sierra Snow: 12-30 inches at Mammoth Mountain; will open Thurs Nov 5! Climate Update: Pacific Ocean Warming. LA...
Bio Investor Forum #3: Finding Value in Biotech Innovation
Biotech Innovation Seeks Value Healthcare Costs Mount The Bio Investor Forum has become a go-to meeting for biotech investors and company executives. Although the presenting companies are early stage or smaller cap public companies the attendees are broadly represented in the industry. And the...
Large Cap Biotech Stocks Get Traction From Revenue Growth…Update-1
10/29/15 Update Large Cap Biotechs Update Amgen (AMGN) Revenues Grow 14%, beats street. 2016 Revenues guided to ~$22B, flattish revenue growth with higher EPS $10.35-$10.75. 2015 PEG=1.80, P/S=5.94, Div. 1.94% Rayno Biopharmaceutical Portfolio Large Caps up 2.6% YTD, IBB up 8% YTD REGN up 37%,...
Bio Investor Forum #2: Three Small Cap Biotech Stocks CRIS,GERN,OCRX…Update-1
Update-1... 11/9 Small Caps Outperform CRIS $2.62, GERN $3.92, OCRX $3.41 Bio Investor Forum-A Runway for Emerging Biotech Companies These are risky times for small cap biotech investments as you know the group took a big hit in July/August and are extremely volatile. Some of our smaller cap...